Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain
- PMID: 28970262
- PMCID: PMC5628037
- DOI: 10.1503/cmaj.733244
Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain
Conflict of interest statement
Competing interests: Erica Weinberg has received speaker fees from Sea Courses. She is also a national faculty member of the Michael G. DeGroote National Pain Centre.
Comment in
-
The authors respond to "Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain".CMAJ. 2017 Oct 2;189(39):E1234-E1235. doi: 10.1503/cmaj.733313. CMAJ. 2017. PMID: 28970263 Free PMC article. No abstract available.
Comment on
-
Guideline for opioid therapy and chronic noncancer pain.CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363. CMAJ. 2017. PMID: 28483845 Free PMC article. No abstract available.
References
-
- Busse J. The 2017 Canadian guideline for opioids for chronic non-cancer pain. Hamilton (ON): McMaster University; 2017. Available: nationalpaincentre.mcmaster.ca (accessed 2017 June 14).
-
- Important safety information on Tylenol with codeine in nursing mothers and ultra-rapid metabolizers of codeine — for health professionals. Ottawa: Health Canada; 2008.
-
- Tramadol (Tramadol hydrochloride) — description and clinical pharmacology. Brooklyn (NY): druglib.com
-
- Opioid formulations with tamper-resistance or abuse-deterrent features — products and policies. Ottawa: CADTH; 2017.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical